Cocrystal Pharma, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cocrystal Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Cocrystal Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.04M, a 13.5% decline year-over-year.
  • Cocrystal Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$19.3M, a 5% decline year-over-year.
  • Cocrystal Pharma, Inc. annual Operating Income (Loss) for 2023 was -$18.6M, a 52.2% increase from 2022.
  • Cocrystal Pharma, Inc. annual Operating Income (Loss) for 2022 was -$38.8M, a 173% decline from 2021.
  • Cocrystal Pharma, Inc. annual Operating Income (Loss) for 2021 was -$14.2M, a 48.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$19.3M -$5.04M -$599K -13.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$18.7M -$5.45M -$1.11M -25.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$17.6M -$4.16M +$953K +18.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$18.6M -$4.67M -$164K -3.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$18.4M -$4.44M +$1.25M +22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$19.6M -$4.34M +$20.1M +82.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$39.7M -$5.11M -$906K -21.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$38.8M -$4.5M -$800K -21.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$38M -$5.69M -$1.74M -44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$36.3M -$24.4M -$20.6M -538% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$15.7M -$4.21M -$1.47M -53.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$14.2M -$3.7M -$2.24M -153% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$12M -$3.95M -$1.24M -45.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$10.7M -$3.83M -$378K -11% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$10.4M -$2.74M -$777K -39.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$9.59M -$1.47M +$46.5M +96.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$56M -$2.71M -$901K -49.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$55.1M -$3.45M -$1.9M -123% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$53.2M -$1.96M -$4.84M -168% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$48.4M -$47.9M +$8.38M +14.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 -$56.8M -$1.81M +$611K +25.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$57.4M -$1.55M +$582K +27.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$58M $2.88M +$4.94M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$62.9M -$56.3M -$54.5M -2975% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$8.45M -$2.42M -$309K -14.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$8.14M -$2.13M -$22K -1.04% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$8.12M -$2.07M +$1.05M +33.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$9.17M -$1.83M +$92.6M +98.1% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-21
Q3 2017 -$102M -$2.11M -$216K -11.4% Jul 1, 2017 Sep 30, 2017 10-K 2018-03-21
Q2 2017 -$102M -$2.11M +$2.09M +49.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-11-09
Q1 2017 -$104M -$3.12M +$2.21M +41.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$106M -$94.4M -$50M -113% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$55.8M -$1.89M +$1.7M +47.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-21
Q2 2016 -$57.5M -$4.2M -$387K -10.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-21
Q1 2016 -$57.1M -$5.33M -$3.17M -146% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-21
Q4 2015 -$53.9M -$44.4M -$42.7M -2571% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$11.2M -$3.59M -$2.37M -195% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$8.87M -$3.82M -$2.43M -175% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$6.44M -$2.17M -$636K -41.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
Q4 2014 -$5.8M -$1.66M -$674K -68.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-31
Q3 2014 -$5.13M -$1.22M -$214K -21.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$4.91M -$1.39M -$356K -34.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.56M -$1.53M -$474K -44.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$4.08M -$987K +$1.58M +61.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$5.66M -$1.01M -$1.34M -397% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.31M -$1.03M -$1.29M -492% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$3.02M -$1.06M -$467K -78.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$2.55M -$2.56M -$1.25M -95.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$1.3M $339K +$2.55M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$3.86M $263K +$722K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$4.58M -$591K -$694K -675% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$3.89M -$1.31M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$2.22M -$2.5M -869% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$460K -$653K -338% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-28
Q1 2011 $103K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-10-02
Q3 2010 $288K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 $193K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.